"","title","geo_accession","status","submission_date","last_update_date","type","channel_count","source_name_ch1","organism_ch1","characteristics_ch1","characteristics_ch1.1","characteristics_ch1.2","characteristics_ch1.3","characteristics_ch1.4","characteristics_ch1.5","characteristics_ch1.6","molecule_ch1","extract_protocol_ch1","label_ch1","label_protocol_ch1","taxid_ch1","hyb_protocol","scan_protocol","description","data_processing","platform_id","contact_name","contact_institute","contact_address","contact_city","contact_state","contact_zip/postal_code","contact_country","supplementary_file","data_row_count","relation"
"GSM526134","Prostate tumor PCA0001 exon","GSM526134","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0001","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T2A","pathological_stage: T3C","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526134/GSM526134_YX_Exon1_PCA0001.CEL.gz","804085","Alternative to: GSM527858 (exon-level analysis)"
"GSM526135","Prostate tumor PCA0002 exon","GSM526135","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0002","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T1C","pathological_stage: T2A","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526135/GSM526135_YX_Exon1_PCA0002.CEL.gz","804085","Alternative to: GSM527859 (exon-level analysis)"
"GSM526136","Prostate tumor PCA0003 exon","GSM526136","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0003","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T2B","pathological_stage: T3A","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526136/GSM526136_YX_Exon1_PCA0003.CEL.gz","804085","Alternative to: GSM527860 (exon-level analysis)"
"GSM526137","Prostate tumor PCA0005 exon","GSM526137","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0005","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T2C","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526137/GSM526137_YX_Exon1_PCA0005.CEL.gz","804085","Alternative to: GSM527861 (exon-level analysis)"
"GSM526138","Prostate tumor PCA0007 exon","GSM526138","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0007","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T1C","pathological_stage: T2C","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526138/GSM526138_YX_Exon1_PCA0007.CEL.gz","804085","Alternative to: GSM527862 (exon-level analysis)"
"GSM526139","Prostate tumor PCA0008 exon","GSM526139","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0008","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T2C","pathological_stage: T3A","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526139/GSM526139_YX_Exon1_PCA0008.CEL.gz","804085","Alternative to: GSM527863 (exon-level analysis)"
"GSM526140","Prostate tumor PCA0009 exon","GSM526140","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0009","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T2A","pathological_stage: T2C","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526140/GSM526140_YX_Exon1_PCA0009.CEL.gz","804085","Alternative to: GSM527864 (exon-level analysis)"
"GSM526141","Prostate tumor PCA0010 exon","GSM526141","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0010","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T4","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526141/GSM526141_YX_Exon1_PCA0010.CEL.gz","804085","Alternative to: GSM527865 (exon-level analysis)"
"GSM526142","Prostate tumor PCA0011 exon","GSM526142","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0011","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T2C","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526142/GSM526142_YX_Exon1_PCA0011.CEL.gz","804085","Alternative to: GSM527866 (exon-level analysis)"
"GSM526143","Prostate tumor PCA0012 exon","GSM526143","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0012","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T2C","pathological_stage: T2C","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526143/GSM526143_YX_Exon1_PCA0012.CEL.gz","804085","Alternative to: GSM527867 (exon-level analysis)"
"GSM526144","Prostate tumor PCA0013 exon","GSM526144","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0013","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T1C","pathological_stage: T3A","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526144/GSM526144_YX_Exon1_PCA0013.CEL.gz","804085","Alternative to: GSM527868 (exon-level analysis)"
"GSM526145","Prostate tumor PCA0014 exon","GSM526145","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0014","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T2C","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526145/GSM526145_YX_Exon1_PCA0014.CEL.gz","804085","Alternative to: GSM527869 (exon-level analysis)"
"GSM526146","Prostate tumor PCA0015 exon","GSM526146","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0015","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T2C","pathological_stage: T3A","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526146/GSM526146_YX_Exon1_PCA0015.CEL.gz","804085","Alternative to: GSM527870 (exon-level analysis)"
"GSM526147","Prostate tumor PCA0017 exon","GSM526147","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0017","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T2A","pathological_stage: T3A","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526147/GSM526147_YX_Exon1_PCA0017.CEL.gz","804085","Alternative to: GSM527871 (exon-level analysis)"
"GSM526148","Prostate tumor PCA0018 exon","GSM526148","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0018","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T2A","pathological_stage: T3A","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526148/GSM526148_YX_Exon1_PCA0018.CEL.gz","804085","Alternative to: GSM527872 (exon-level analysis)"
"GSM526149","Prostate tumor PCA0020 exon","GSM526149","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0020","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T2B","pathological_stage: T3A","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526149/GSM526149_YX_Exon1_PCA0020.CEL.gz","804085","Alternative to: GSM527873 (exon-level analysis)"
"GSM526150","Prostate tumor PCA0021 exon","GSM526150","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0021","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T2C","pathological_stage: T3A","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526150/GSM526150_YX_Exon1_PCA0021.CEL.gz","804085","Alternative to: GSM527874 (exon-level analysis)"
"GSM526151","Prostate tumor PCA0022 exon","GSM526151","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0022","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T2C","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526151/GSM526151_YX_Exon1_PCA0022.CEL.gz","804085","Alternative to: GSM527875 (exon-level analysis)"
"GSM526152","Prostate tumor PCA0024 exon","GSM526152","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0024","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T1C","pathological_stage: T2C","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526152/GSM526152_YX_Exon1_PCA0024.CEL.gz","804085","Alternative to: GSM527876 (exon-level analysis)"
"GSM526153","Prostate tumor PCA0025 exon","GSM526153","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0025","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T2B","pathological_stage: T2C","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526153/GSM526153_YX_Exon1_PCA0025.CEL.gz","804085","Alternative to: GSM527877 (exon-level analysis)"
"GSM526154","Prostate tumor PCA0026 exon","GSM526154","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0026","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T2A","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526154/GSM526154_YX_Exon1_PCA0026.CEL.gz","804085","Alternative to: GSM527878 (exon-level analysis)"
"GSM526155","Prostate tumor PCA0027 exon","GSM526155","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0027","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 5","clint_stage: T1C","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526155/GSM526155_YX_Exon1_PCA0027.CEL.gz","804085","Alternative to: GSM527879 (exon-level analysis)"
"GSM526156","Prostate tumor PCA0028 exon","GSM526156","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0028","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T3B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526156/GSM526156_YX_Exon1_PCA0028.CEL.gz","804085","Alternative to: GSM527880 (exon-level analysis)"
"GSM526157","Prostate tumor PCA0029 exon","GSM526157","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0029","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T2B","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526157/GSM526157_YX_Exon1_PCA0029.CEL.gz","804085","Alternative to: GSM527881 (exon-level analysis)"
"GSM526158","Prostate tumor PCA0030 exon","GSM526158","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0030","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T2A","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526158/GSM526158_YX_Exon1_PCA0030.CEL.gz","804085","Alternative to: GSM527882 (exon-level analysis)"
"GSM526159","Prostate tumor PCA0031 exon","GSM526159","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0031","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 8","clint_stage: T2A","pathological_stage: T3A","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526159/GSM526159_YX_Exon1_PCA0031.CEL.gz","804085","Alternative to: GSM527883 (exon-level analysis)"
"GSM526160","Prostate tumor PCA0032 exon","GSM526160","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0032","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T2A","pathological_stage: T3A","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526160/GSM526160_YX_Exon1_PCA0032.CEL.gz","804085","Alternative to: GSM527884 (exon-level analysis)"
"GSM526161","Prostate tumor PCA0033 exon","GSM526161","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0033","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T2B","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526161/GSM526161_YX_Exon1_PCA0033.CEL.gz","804085","Alternative to: GSM527885 (exon-level analysis)"
"GSM526162","Prostate tumor PCA0034 exon","GSM526162","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0034","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526162/GSM526162_YX_Exon1_PCA0034.CEL.gz","804085","Alternative to: GSM527886 (exon-level analysis)"
"GSM526163","Prostate tumor PCA0035 exon","GSM526163","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0035","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T2B","pathological_stage: T3A","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526163/GSM526163_YX_Exon1_PCA0035.CEL.gz","804085","Alternative to: GSM527887 (exon-level analysis)"
"GSM526164","Prostate tumor PCA0036 exon","GSM526164","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0036","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T2A","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526164/GSM526164_YX_Exon1_PCA0036.CEL.gz","804085","Alternative to: GSM527888 (exon-level analysis)"
"GSM526165","Prostate tumor PCA0037 exon","GSM526165","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0037","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T2A","pathological_stage: T2A","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526165/GSM526165_YX_Exon1_PCA0037.CEL.gz","804085","Alternative to: GSM527889 (exon-level analysis)"
"GSM526166","Prostate tumor PCA0038 exon","GSM526166","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0038","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 9","clint_stage: T2B","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526166/GSM526166_YX_PCA0038_HuEx_1.CEL.gz","804085","Alternative to: GSM527890 (exon-level analysis)"
"GSM526167","Prostate tumor PCA0040 exon","GSM526167","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0040","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T2A","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526167/GSM526167_YX_Exon1_PCA0040.CEL.gz","804085","Alternative to: GSM527891 (exon-level analysis)"
"GSM526168","Prostate tumor PCA0050 exon","GSM526168","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0050","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T2B","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526168/GSM526168_YX_Exon1_PCA0050.CEL.gz","804085","Alternative to: GSM527892 (exon-level analysis)"
"GSM526169","Prostate tumor PCA0052 exon","GSM526169","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0052","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T3A","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526169/GSM526169_YX_Exon1_PCA0052.CEL.gz","804085","Alternative to: GSM527893 (exon-level analysis)"
"GSM526170","Prostate tumor PCA0054 exon","GSM526170","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0054","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T1C","pathological_stage: T3C","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526170/GSM526170_YX_Exon1_PCA0054.CEL.gz","804085","Alternative to: GSM527894 (exon-level analysis)"
"GSM526171","Prostate tumor PCA0056 exon","GSM526171","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0056","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T2A","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526171/GSM526171_YX_Exon1_PCA0056.CEL.gz","804085","Alternative to: GSM527895 (exon-level analysis)"
"GSM526172","Prostate tumor PCA0057 exon","GSM526172","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0057","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526172/GSM526172_YX_Exon1_PCA0057.CEL.gz","804085","Alternative to: GSM527896 (exon-level analysis)"
"GSM526173","Prostate tumor PCA0058 exon","GSM526173","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0058","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T2C","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526173/GSM526173_YX_PCA0058_HuEx_1.CEL.gz","804085","Alternative to: GSM527897 (exon-level analysis)"
"GSM526174","Prostate tumor PCA0062 exon","GSM526174","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0062","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526174/GSM526174_YX_Exon1_PCA0062.CEL.gz","804085","Alternative to: GSM527898 (exon-level analysis)"
"GSM526175","Prostate tumor PCA0063 exon","GSM526175","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0063","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T2B","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526175/GSM526175_YX_Exon1_PCA0063.CEL.gz","804085","Alternative to: GSM527899 (exon-level analysis)"
"GSM526176","Prostate tumor PCA0064 exon","GSM526176","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0064","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T2B","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526176/GSM526176_YX_Exon1_PCA0064.CEL.gz","804085","Alternative to: GSM527900 (exon-level analysis)"
"GSM526177","Prostate tumor PCA0065 exon","GSM526177","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0065","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526177/GSM526177_YX_Exon1_PCA0065.CEL.gz","804085","Alternative to: GSM527901 (exon-level analysis)"
"GSM526178","Prostate tumor PCA0066 exon","GSM526178","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0066","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T2B","pathological_stage: T3B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526178/GSM526178_YX_Exon1_PCA0066.CEL.gz","804085","Alternative to: GSM527902 (exon-level analysis)"
"GSM526179","Prostate tumor PCA0068 exon","GSM526179","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0068","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T2B","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526179/GSM526179_YX_Exon1_PCA0068.CEL.gz","804085","Alternative to: GSM527903 (exon-level analysis)"
"GSM526180","Prostate tumor PCA0073 exon","GSM526180","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0073","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T3A","pathological_stage: T3A","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526180/GSM526180_YX_Exon1_PCA0073.CEL.gz","804085","Alternative to: GSM527904 (exon-level analysis)"
"GSM526181","Prostate tumor PCA0074 exon","GSM526181","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0074","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T1C","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526181/GSM526181_YX_Exon1_PCA0074.CEL.gz","804085","Alternative to: GSM527905 (exon-level analysis)"
"GSM526182","Prostate tumor PCA0075 exon","GSM526182","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0075","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T2A","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526182/GSM526182_YX_Exon1_PCA0075.CEL.gz","804085","Alternative to: GSM527906 (exon-level analysis)"
"GSM526183","Prostate tumor PCA0077 exon","GSM526183","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0077","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T2B","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526183/GSM526183_YX_Exon1_PCA0077.CEL.gz","804085","Alternative to: GSM527907 (exon-level analysis)"
"GSM526184","Prostate tumor PCA0080 exon","GSM526184","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0080","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 8","clint_stage: T1C","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526184/GSM526184_YX_Exon1_PCA0080.CEL.gz","804085","Alternative to: GSM527908 (exon-level analysis)"
"GSM526185","Prostate tumor PCA0081 exon","GSM526185","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0081","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T2B","pathological_stage: T4","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526185/GSM526185_YX_Exon1_PCA0081.CEL.gz","804085","Alternative to: GSM527909 (exon-level analysis)"
"GSM526186","Prostate tumor PCA0082 exon","GSM526186","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0082","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526186/GSM526186_YX_Exon1_PCA0082.CEL.gz","804085","Alternative to: GSM527910 (exon-level analysis)"
"GSM526187","Prostate tumor PCA0083 exon","GSM526187","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0083","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T3","pathological_stage: T3A","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526187/GSM526187_YX_Exon1_PCA0083.CEL.gz","804085","Alternative to: GSM527911 (exon-level analysis)"
"GSM526188","Prostate tumor PCA0084 exon","GSM526188","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0084","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526188/GSM526188_YX_PCA0084_HuEx_1.CEL.gz","804085","Alternative to: GSM527912 (exon-level analysis)"
"GSM526189","Prostate tumor PCA0086 exon","GSM526189","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0086","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T1C","pathological_stage: T2A","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526189/GSM526189_YX_Exon1_PCA0086.CEL.gz","804085","Alternative to: GSM527913 (exon-level analysis)"
"GSM526190","Prostate tumor PCA0087 exon","GSM526190","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0087","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T2C","pathological_stage: T3A","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526190/GSM526190_YX_Exon1_PCA0087.CEL.gz","804085","Alternative to: GSM527914 (exon-level analysis)"
"GSM526191","Prostate tumor PCA0089 exon","GSM526191","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0089","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T2C","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526191/GSM526191_YX_Exon1_PCA0089.CEL.gz","804085","Alternative to: GSM527915 (exon-level analysis)"
"GSM526192","Prostate tumor PCA0090 exon","GSM526192","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0090","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T3B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526192/GSM526192_YX_Exon1_PCA0090.CEL.gz","804085","Alternative to: GSM527916 (exon-level analysis)"
"GSM526193","Prostate tumor PCA0092 exon","GSM526193","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0092","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T3A","pathological_stage: T4","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526193/GSM526193_YX_Exon1_PCA0092.CEL.gz","804085","Alternative to: GSM527917 (exon-level analysis)"
"GSM526194","Prostate tumor PCA0093 exon","GSM526194","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0093","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526194/GSM526194_YX_Exon1_PCA0093.CEL.gz","804085","Alternative to: GSM527918 (exon-level analysis)"
"GSM526195","Prostate tumor PCA0094 exon","GSM526195","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0094","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526195/GSM526195_YX_Exon1_PCA0094.CEL.gz","804085","Alternative to: GSM527919 (exon-level analysis)"
"GSM526196","Prostate tumor PCA0095 exon","GSM526196","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0095","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T4","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526196/GSM526196_YX_Exon1_PCA0095.CEL.gz","804085","Alternative to: GSM527920 (exon-level analysis)"
"GSM526197","Prostate tumor PCA0096 exon","GSM526197","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0096","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T2A","pathological_stage: T3B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526197/GSM526197_YX_Exon1_PCA0096.CEL.gz","804085","Alternative to: GSM527921 (exon-level analysis)"
"GSM526198","Prostate tumor PCA0097 exon","GSM526198","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0097","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526198/GSM526198_YX_Exon1_PCA0097.CEL.gz","804085","Alternative to: GSM527922 (exon-level analysis)"
"GSM526199","Prostate tumor PCA0099 exon","GSM526199","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0099","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 9","clint_stage: T2C","pathological_stage: T3A","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526199/GSM526199_YX_Exon1_PCA0099.CEL.gz","804085","Alternative to: GSM527923 (exon-level analysis)"
"GSM526200","Prostate tumor PCA0100 exon","GSM526200","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0100","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T2A","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526200/GSM526200_YX_Exon1_PCA0100.CEL.gz","804085","Alternative to: GSM527924 (exon-level analysis)"
"GSM526201","Prostate tumor PCA0101 exon","GSM526201","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0101","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526201/GSM526201_YX_Exon1_PCA0101.CEL.gz","804085","Alternative to: GSM527925 (exon-level analysis)"
"GSM526202","Prostate tumor PCA0103 exon","GSM526202","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0103","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T1C","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526202/GSM526202_YX_Exon1_PCA0103.CEL.gz","804085","Alternative to: GSM527926 (exon-level analysis)"
"GSM526203","Prostate tumor PCA0104 exon","GSM526203","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0104","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T2A","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526203/GSM526203_YX_Exon1_PCA0104.CEL.gz","804085","Alternative to: GSM527927 (exon-level analysis)"
"GSM526204","Prostate tumor PCA0105 exon","GSM526204","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0105","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T2C","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526204/GSM526204_YX_Exon1_PCA0105.CEL.gz","804085","Alternative to: GSM527928 (exon-level analysis)"
"GSM526205","Prostate tumor PCA0107 exon","GSM526205","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0107","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T2B","pathological_stage: T2C","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526205/GSM526205_YX_Exon1_PCA0107.CEL.gz","804085","Alternative to: GSM527929 (exon-level analysis)"
"GSM526206","Prostate tumor PCA0108 exon","GSM526206","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0108","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T3A","pathological_stage: T3A","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526206/GSM526206_YX_Exon1_PCA0108.CEL.gz","804085","Alternative to: GSM527930 (exon-level analysis)"
"GSM526207","Prostate tumor PCA0109 exon","GSM526207","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0109","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526207/GSM526207_YX_Exon1_PCA0109.CEL.gz","804085","Alternative to: GSM527931 (exon-level analysis)"
"GSM526208","Prostate tumor PCA0110 exon","GSM526208","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0110","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T2C","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526208/GSM526208_YX_Exon1_PCA0110.CEL.gz","804085","Alternative to: GSM527932 (exon-level analysis)"
"GSM526209","Prostate tumor PCA0111 exon","GSM526209","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0111","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T1C","pathological_stage: T2C","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526209/GSM526209_YX_Exon1_PCA0111.CEL.gz","804085","Alternative to: GSM527933 (exon-level analysis)"
"GSM526210","Prostate tumor PCA0112 exon","GSM526210","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0112","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 8","clint_stage: T3A","pathological_stage: T3A","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526210/GSM526210_YX_Exon1_PCA0112.CEL.gz","804085","Alternative to: GSM527934 (exon-level analysis)"
"GSM526211","Prostate tumor PCA0113 exon","GSM526211","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0113","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T1C","pathological_stage: T2C","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526211/GSM526211_YX_Exon1_PCA0113.CEL.gz","804085","Alternative to: GSM527935 (exon-level analysis)"
"GSM526212","Prostate tumor PCA0114 exon","GSM526212","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0114","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T3A","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526212/GSM526212_YX_Exon1_PCA0114.CEL.gz","804085","Alternative to: GSM527936 (exon-level analysis)"
"GSM526213","Prostate tumor PCA0115 exon","GSM526213","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0115","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T2A","pathological_stage: T2C","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526213/GSM526213_YX_Exon1_PCA0115.CEL.gz","804085","Alternative to: GSM527937 (exon-level analysis)"
"GSM526214","Prostate tumor PCA0117 exon","GSM526214","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0117","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 8","clint_stage: T1C","pathological_stage: T3B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526214/GSM526214_YX_Exon1_PCA0117.CEL.gz","804085","Alternative to: GSM527938 (exon-level analysis)"
"GSM526215","Prostate tumor PCA0118 exon","GSM526215","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0118","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526215/GSM526215_YX_Exon1_PCA0118.CEL.gz","804085","Alternative to: GSM527939 (exon-level analysis)"
"GSM526216","Prostate tumor PCA0119 exon","GSM526216","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0119","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526216/GSM526216_YX_Exon1_PCA0119.CEL.gz","804085","Alternative to: GSM527940 (exon-level analysis)"
"GSM526217","Prostate tumor PCA0120 exon","GSM526217","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0120","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T2A","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526217/GSM526217_YX_Exon1_PCA0120.CEL.gz","804085","Alternative to: GSM527941 (exon-level analysis)"
"GSM526218","Prostate tumor PCA0122 exon","GSM526218","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0122","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526218/GSM526218_YX_Exon1_PCA0122.CEL.gz","804085","Alternative to: GSM527942 (exon-level analysis)"
"GSM526219","Prostate tumor PCA0123 exon","GSM526219","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0123","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T2C","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526219/GSM526219_YX_Exon1_PCA0123.CEL.gz","804085","Alternative to: GSM527943 (exon-level analysis)"
"GSM526220","Prostate tumor PCA0124 exon","GSM526220","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0124","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T2A","pathological_stage: T2C","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526220/GSM526220_YX_Exon1_PCA0124.CEL.gz","804085","Alternative to: GSM527944 (exon-level analysis)"
"GSM526221","Prostate tumor PCA0125 exon","GSM526221","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0125","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T2C","pathological_stage: T3A","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526221/GSM526221_YX_Exon1_PCA0125.CEL.gz","804085","Alternative to: GSM527945 (exon-level analysis)"
"GSM526222","Prostate tumor PCA0126 exon","GSM526222","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0126","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T2C","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526222/GSM526222_YX_Exon1_PCA0126.CEL.gz","804085","Alternative to: GSM527946 (exon-level analysis)"
"GSM526223","Prostate tumor PCA0127 exon","GSM526223","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0127","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 8","clint_stage: T2A","pathological_stage: T2C","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526223/GSM526223_YX_Exon1_PCA0127.CEL.gz","804085","Alternative to: GSM527947 (exon-level analysis)"
"GSM526224","Prostate tumor PCA0128 exon","GSM526224","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0128","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T2A","pathological_stage: T2C","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526224/GSM526224_YX_Exon1_PCA0128.CEL.gz","804085","Alternative to: GSM527948 (exon-level analysis)"
"GSM526225","Prostate tumor PCA0129 exon","GSM526225","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0129","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T2A","pathological_stage: T2C","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526225/GSM526225_YX_Exon1_PCA0129.CEL.gz","804085","Alternative to: GSM527949 (exon-level analysis)"
"GSM526226","Prostate tumor PCA0130 exon","GSM526226","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0130","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 8","clint_stage: T1C","pathological_stage: T2C","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526226/GSM526226_YX_Exon1_PCA0130.CEL.gz","804085","Alternative to: GSM527950 (exon-level analysis)"
"GSM526227","Prostate tumor PCA0132 exon","GSM526227","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0132","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T2A","pathological_stage: T2C","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526227/GSM526227_YX_Exon1_PCA0132.CEL.gz","804085","Alternative to: GSM527951 (exon-level analysis)"
"GSM526228","Prostate tumor PCA0133 exon","GSM526228","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0133","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526228/GSM526228_YX_Exon1_PCA0133.CEL.gz","804085","Alternative to: GSM527952 (exon-level analysis)"
"GSM526229","Prostate tumor PCA0134 exon","GSM526229","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0134","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T2A","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526229/GSM526229_YX_Exon1_PCA0134.CEL.gz","804085","Alternative to: GSM527953 (exon-level analysis)"
"GSM526230","Prostate tumor PCA0135 exon","GSM526230","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0135","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526230/GSM526230_YX_Exon1_PCA0135.CEL.gz","804085","Alternative to: GSM527954 (exon-level analysis)"
"GSM526231","Prostate tumor PCA0136 exon","GSM526231","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0136","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T3A","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526231/GSM526231_YX_Exon1_PCA0136.CEL.gz","804085","Alternative to: GSM527955 (exon-level analysis)"
"GSM526232","Prostate tumor PCA0141 exon","GSM526232","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0141","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T2A","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526232/GSM526232_YX_Exon1_PCA0141.CEL.gz","804085","Alternative to: GSM527956 (exon-level analysis)"
"GSM526233","Prostate tumor PCA0144 exon","GSM526233","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0144","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T1C","pathological_stage: T2C","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526233/GSM526233_YX_Exon1_PCA0144.CEL.gz","804085","Alternative to: GSM527957 (exon-level analysis)"
"GSM526234","Prostate tumor PCA0145 exon","GSM526234","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0145","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T1C","pathological_stage: T2C","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526234/GSM526234_YX_Exon1_PCA0145.CEL.gz","804085","Alternative to: GSM527958 (exon-level analysis)"
"GSM526235","Prostate tumor PCA0146 exon","GSM526235","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0146","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T2C","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526235/GSM526235_YX_Exon1_PCA0146.CEL.gz","804085","Alternative to: GSM527959 (exon-level analysis)"
"GSM526236","Prostate tumor PCA0147 exon","GSM526236","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0147","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T2C","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526236/GSM526236_YX_Exon1_PCA0147.CEL.gz","804085","Alternative to: GSM527960 (exon-level analysis)"
"GSM526237","Prostate tumor PCA0149 exon","GSM526237","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0149","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T2C","pathological_stage: T3B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526237/GSM526237_YX_Exon1_PCA0149.CEL.gz","804085","Alternative to: GSM527961 (exon-level analysis)"
"GSM526238","Prostate tumor PCA0150 exon","GSM526238","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0150","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T2B","pathological_stage: T3A","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526238/GSM526238_YX_PCA0150_HuEx_1.CEL.gz","804085","Alternative to: GSM527962 (exon-level analysis)"
"GSM526239","Prostate tumor PCA0151 exon","GSM526239","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0151","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526239/GSM526239_YX_Exon1_PCA0151.CEL.gz","804085","Alternative to: GSM527963 (exon-level analysis)"
"GSM526240","Prostate tumor PCA0155 exon","GSM526240","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0155","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T2A","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526240/GSM526240_YX_Exon1_PCA0155.CEL.gz","804085","Alternative to: GSM527965 (exon-level analysis)"
"GSM526241","Prostate tumor PCA0156 exon","GSM526241","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0156","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T1C","pathological_stage: T4","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526241/GSM526241_YX_Exon1_PCA0156.CEL.gz","804085","Alternative to: GSM527966 (exon-level analysis)"
"GSM526242","Prostate tumor PCA0157 exon","GSM526242","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0157","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T3A","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526242/GSM526242_YX_Exon1_PCA0157.CEL.gz","804085","Alternative to: GSM527968 (exon-level analysis)"
"GSM526243","Prostate tumor PCA0158 exon","GSM526243","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0158","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T2C","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526243/GSM526243_YX_Exon1_PCA0158.CEL.gz","804085","Alternative to: GSM527970 (exon-level analysis)"
"GSM526244","Prostate tumor PCA0159 exon","GSM526244","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0159","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T2A","pathological_stage: T3B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526244/GSM526244_YX_Exon1_PCA0159.CEL.gz","804085","Alternative to: GSM527971 (exon-level analysis)"
"GSM526245","Prostate tumor PCA0160 exon","GSM526245","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0160","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T2A","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526245/GSM526245_YX_Exon1_PCA0160.CEL.gz","804085","Alternative to: GSM527972 (exon-level analysis)"
"GSM526246","Prostate tumor PCA0161 exon","GSM526246","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0161","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526246/GSM526246_YX_Exon1_PCA0161.CEL.gz","804085","Alternative to: GSM527973 (exon-level analysis)"
"GSM526247","Prostate tumor PCA0162 exon","GSM526247","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0162","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T1C","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526247/GSM526247_YX_Exon1_PCA0162.CEL.gz","804085","Alternative to: GSM527974 (exon-level analysis)"
"GSM526248","Prostate tumor PCA0163 exon","GSM526248","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0163","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T1C","pathological_stage: T3A","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526248/GSM526248_YX_Exon1_PCA0163.CEL.gz","804085","Alternative to: GSM527975 (exon-level analysis)"
"GSM526249","Prostate tumor PCA0164 exon","GSM526249","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0164","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526249/GSM526249_YX_Exon1_PCA0164.CEL.gz","804085","Alternative to: GSM527977 (exon-level analysis)"
"GSM526250","Prostate tumor PCA0165 exon","GSM526250","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0165","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526250/GSM526250_YX_Exon1_PCA0165.CEL.gz","804085","Alternative to: GSM527979 (exon-level analysis)"
"GSM526251","Prostate tumor PCA0167 exon","GSM526251","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0167","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T2B","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526251/GSM526251_YX_Exon1_PCA0167.CEL.gz","804085","Alternative to: GSM527980 (exon-level analysis)"
"GSM526252","Prostate tumor PCA0168 exon","GSM526252","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0168","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T2C","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526252/GSM526252_YX_Exon1_PCA0168.CEL.gz","804085","Alternative to: GSM527982 (exon-level analysis)"
"GSM526253","Prostate tumor PCA0169 exon","GSM526253","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0169","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526253/GSM526253_YX_Exon1_PCA0169.CEL.gz","804085","Alternative to: GSM527984 (exon-level analysis)"
"GSM526254","Prostate tumor PCA0170 exon","GSM526254","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0170","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T2B","pathological_stage: T3A","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526254/GSM526254_YX_Exon1_PCA0170.CEL.gz","804085","Alternative to: GSM527985 (exon-level analysis)"
"GSM526255","Prostate tumor PCA0171 exon","GSM526255","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0171","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T2A","pathological_stage: T3A","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526255/GSM526255_YX_Exon1_PCA0171.CEL.gz","804085","Alternative to: GSM527986 (exon-level analysis)"
"GSM526256","Prostate tumor PCA0172 exon","GSM526256","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0172","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 8","clint_stage: T1C","pathological_stage: T4","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526256/GSM526256_YX_Exon1_PCA0172.CEL.gz","804085","Alternative to: GSM527987 (exon-level analysis)"
"GSM526257","Prostate tumor PCA0173 exon","GSM526257","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0173","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T1C","pathological_stage: T3B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526257/GSM526257_YX_Exon1_PCA0173.CEL.gz","804085","Alternative to: GSM527988 (exon-level analysis)"
"GSM526258","Prostate tumor PCA0174 exon","GSM526258","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0174","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T1C","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526258/GSM526258_YX_Exon1_PCA0174.CEL.gz","804085","Alternative to: GSM527989 (exon-level analysis)"
"GSM526259","Prostate tumor PCA0175 exon","GSM526259","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0175","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T1C","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526259/GSM526259_YX_Exon1_PCA0175.CEL.gz","804085","Alternative to: GSM527990 (exon-level analysis)"
"GSM526260","Prostate tumor PCA0176 exon","GSM526260","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0176","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T3B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526260/GSM526260_YX_Exon1_PCA0176.CEL.gz","804085","Alternative to: GSM527991 (exon-level analysis)"
"GSM526261","Prostate tumor PCA0178 exon","GSM526261","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0178","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526261/GSM526261_YX_Exon1_PCA0178.CEL.gz","804085","Alternative to: GSM527992 (exon-level analysis)"
"GSM526262","Prostate tumor PCA0179 exon","GSM526262","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0179","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 9","clint_stage: T1C","pathological_stage: T3B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526262/GSM526262_YX_Exon1_PCA0179.CEL.gz","804085","Alternative to: GSM527993 (exon-level analysis)"
"GSM526263","Prostate tumor PCA0180 exon","GSM526263","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0180","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 7","clint_stage: T1C","pathological_stage: T3A","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526263/GSM526263_YX_Exon1_PCA0180.CEL.gz","804085","Alternative to: GSM527994 (exon-level analysis)"
"GSM526264","Prostate tumor PCA0181 exon","GSM526264","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0181","tissue: Prostate","disease status: prostate cancer","tumor type: Primary tumor","biopsy_gleason_grade: 9","clint_stage: T1C","pathological_stage: T3A","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526264/GSM526264_YX_Exon1_PCA0181.CEL.gz","804085","Alternative to: GSM527995 (exon-level analysis)"
"GSM526265","Prostate tumor PCA0182 exon","GSM526265","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0182","tissue: Prostate","disease status: prostate cancer","tumor type: Metastasis","biopsy_gleason_grade: 7","clint_stage: T2","pathological_stage: NA","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526265/GSM526265_YX_Exon1_PCA0182.CEL.gz","804085","Alternative to: GSM527996 (exon-level analysis)"
"GSM526266","Prostate tumor PCA0184 exon","GSM526266","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0184","tissue: Prostate","disease status: prostate cancer","tumor type: Metastasis","biopsy_gleason_grade: 6","clint_stage: T1C","pathological_stage: NA","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526266/GSM526266_YX_Exon1_PCA0184.CEL.gz","804085","Alternative to: GSM527997 (exon-level analysis)"
"GSM526267","Prostate tumor PCA0187 exon","GSM526267","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0187","tissue: Prostate","disease status: prostate cancer","tumor type: Metastasis","biopsy_gleason_grade: 7","clint_stage: T2C","pathological_stage: T2B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526267/GSM526267_YX_Exon1_PCA0187.CEL.gz","804085","Alternative to: GSM527998 (exon-level analysis)"
"GSM526268","Prostate tumor PCA0188 exon","GSM526268","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0188","tissue: Prostate","disease status: prostate cancer","tumor type: Metastasis","biopsy_gleason_grade: 9","clint_stage: NA","pathological_stage: NA","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526268/GSM526268_YX_Exon1_PCA0188.CEL.gz","804085","Alternative to: GSM527999 (exon-level analysis)"
"GSM526269","Prostate tumor PCA0189 exon","GSM526269","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0189","tissue: Prostate","disease status: prostate cancer","tumor type: Metastasis","biopsy_gleason_grade: 8","clint_stage: T2B","pathological_stage: NA","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526269/GSM526269_YX_Exon1_PCA0189.CEL.gz","804085","Alternative to: GSM528000 (exon-level analysis)"
"GSM526270","Prostate tumor PCA0190 exon","GSM526270","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0190","tissue: Prostate","disease status: prostate cancer","tumor type: Metastasis","biopsy_gleason_grade: NA","clint_stage: NA","pathological_stage: NA","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526270/GSM526270_YX_Exon1_PCA0190.CEL.gz","804085","Alternative to: GSM528001 (exon-level analysis)"
"GSM526271","Prostate tumor PCA0193 exon","GSM526271","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0193","tissue: Prostate","disease status: prostate cancer","tumor type: Metastasis","biopsy_gleason_grade: 9","clint_stage: T2A","pathological_stage: NA","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526271/GSM526271_YX_Exon1_PCA0193.CEL.gz","804085","Alternative to: GSM528002 (exon-level analysis)"
"GSM526272","Prostate tumor PCA0194 exon","GSM526272","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0194","tissue: Prostate","disease status: prostate cancer","tumor type: Metastasis","biopsy_gleason_grade: 6","clint_stage: NA","pathological_stage: NA","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526272/GSM526272_YX_Exon1_PCA0194.CEL.gz","804085","Alternative to: GSM528003 (exon-level analysis)"
"GSM526273","Prostate tumor PCA0199 exon","GSM526273","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0199","tissue: Prostate","disease status: prostate cancer","tumor type: Metastasis","biopsy_gleason_grade: 9","clint_stage: T4","pathological_stage: T4","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526273/GSM526273_YX_Exon1_PCA0199.CEL.gz","804085","Alternative to: GSM528004 (exon-level analysis)"
"GSM526274","Prostate tumor PCA0200 exon","GSM526274","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0200","tissue: Prostate","disease status: prostate cancer","tumor type: Metastasis","biopsy_gleason_grade: 9","clint_stage: T1C","pathological_stage: T3B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526274/GSM526274_YX_Exon1_PCA0200.CEL.gz","804085","Alternative to: GSM528005 (exon-level analysis)"
"GSM526275","Prostate tumor PCA0201 exon","GSM526275","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0201","tissue: Prostate","disease status: prostate cancer","tumor type: Metastasis","biopsy_gleason_grade: 7","clint_stage: T2C","pathological_stage: T3B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526275/GSM526275_YX_Exon1_PCA0201.CEL.gz","804085","Alternative to: GSM528006 (exon-level analysis)"
"GSM526276","Prostate tumor PCA0206 exon","GSM526276","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0206","tissue: Prostate","disease status: prostate cancer","tumor type: Metastasis","biopsy_gleason_grade: 7","clint_stage: T1C","pathological_stage: T4","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526276/GSM526276_YX_Exon1_PCA0206.CEL.gz","804085","Alternative to: GSM528007 (exon-level analysis)"
"GSM526277","Prostate tumor PCA0207 exon","GSM526277","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0207","tissue: Prostate","disease status: prostate cancer","tumor type: Metastasis","biopsy_gleason_grade: 7","clint_stage: T1C","pathological_stage: T3A","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526277/GSM526277_YX_Exon1_PCA0207.CEL.gz","804085","Alternative to: GSM528008 (exon-level analysis)"
"GSM526278","Prostate tumor PCA0208 exon","GSM526278","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0208","tissue: Prostate","disease status: prostate cancer","tumor type: Metastasis","biopsy_gleason_grade: 7","clint_stage: T1C","pathological_stage: T3B","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526278/GSM526278_YX_Exon1_PCA0208.CEL.gz","804085","Alternative to: GSM528009 (exon-level analysis)"
"GSM526279","Prostate tumor PCA0209 exon","GSM526279","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0209","tissue: Prostate","disease status: prostate cancer","tumor type: Metastasis","biopsy_gleason_grade: 8","clint_stage: T2C","pathological_stage: NA","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526279/GSM526279_YX_PCA0209_HuEx_1.CEL.gz","804085","Alternative to: GSM528010 (exon-level analysis)"
"GSM526280","Prostate tumor PCA0210 exon","GSM526280","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0210","tissue: Prostate","disease status: prostate cancer","tumor type: Metastasis","biopsy_gleason_grade: 7","clint_stage: T2B","pathological_stage: T3C","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526280/GSM526280_YX_PCA0210_HuEx_1.CEL.gz","804085","Alternative to: GSM528011 (exon-level analysis)"
"GSM526281","Prostate tumor PCA0211 exon","GSM526281","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0211","tissue: Prostate","disease status: prostate cancer","tumor type: Metastasis","biopsy_gleason_grade: 9","clint_stage: NA","pathological_stage: NA","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526281/GSM526281_YX_Exon1_PCA0211.CEL.gz","804085","Alternative to: GSM528012 (exon-level analysis)"
"GSM526282","Prostate tumor PCA0213 exon","GSM526282","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0213","tissue: Prostate","disease status: prostate cancer","tumor type: Metastasis","biopsy_gleason_grade: 7","clint_stage: NA","pathological_stage: T3C","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526282/GSM526282_YX_Exon1_PCA0213.CEL.gz","804085","Alternative to: GSM528013 (exon-level analysis)"
"GSM526283","Prostate tumor PCA0215 exon","GSM526283","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate","Homo sapiens","sample id: PCA0215","tissue: Prostate","disease status: prostate cancer","tumor type: Metastasis","biopsy_gleason_grade: 8","clint_stage: T3","pathological_stage: T3A","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526283/GSM526283_YX_PCA0215_HuEx_1.CEL.gz","804085","Alternative to: GSM528014 (exon-level analysis)"
"GSM526284","Cell line DU145 exon","GSM526284","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate cancer cell line","Homo sapiens","sample id: DU145","tissue: Prostate","cell line: DU145","","","","","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526284/GSM526284_YX_Exon1_DU145.CEL.gz","804085","Alternative to: GSM528015 (exon-level analysis)"
"GSM526285","Cell line LNCaP exon","GSM526285","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate cancer cell line","Homo sapiens","sample id: LNCaP","tissue: Prostate","cell line: LNCaP","","","","","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526285/GSM526285_YX_Exon1_LNCaP.CEL.gz","804085","Alternative to: GSM528016 (exon-level analysis)"
"GSM526286","Xenograft LNCaP104R exon","GSM526286","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate xenograft","Homo sapiens","sample id: LNCaP104R","tissue: Prostate","cell type: Xenograft LNCaP104R","","","","","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526286/GSM526286_YX_Exon1_LNCaP104R.CEL.gz","804085","Alternative to: GSM528017 (exon-level analysis)"
"GSM526287","Xenograft LNCaP104S exon","GSM526287","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate xenograft","Homo sapiens","sample id: LNCaP104S","tissue: Prostate","cell type: Xenograft LNCaP104S","","","","","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526287/GSM526287_YX_Exon1_LNCaP104S.CEL.gz","804085","Alternative to: GSM528018 (exon-level analysis)"
"GSM526288","Cell line PC3 exon","GSM526288","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate cancer cell line","Homo sapiens","sample id: PC3","tissue: Prostate","cell line: PC3","","","","","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526288/GSM526288_YX_Exon1_PC3.CEL.gz","804085","Alternative to: GSM528019 (exon-level analysis)"
"GSM526289","Cell line Vcap exon","GSM526289","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human prostate cancer cell line","Homo sapiens","sample id: Vcap","tissue: Prostate","cell line: Vcap","","","","","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526289/GSM526289_YX_Exon1_Vcap.CEL.gz","804085","Alternative to: GSM528020 (exon-level analysis)"
"GSM526290","Prostate normal PAN0095 exon","GSM526290","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human adjacent normal prostate","Homo sapiens","sample id: PAN0095","tissue: Prostate","disease status: normal adjacent benign prostate","","","","","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526290/GSM526290_YX_Exon1_PAN0095.CEL.gz","804085","Alternative to: GSM528021 (exon-level analysis)"
"GSM526291","Prostate normal PAN0107 exon","GSM526291","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human adjacent normal prostate","Homo sapiens","sample id: PAN0107","tissue: Prostate","disease status: normal adjacent benign prostate","","","","","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526291/GSM526291_YX_Exon1_PAN0107.CEL.gz","804085","Alternative to: GSM528022 (exon-level analysis)"
"GSM526292","Prostate normal PAN0109 exon","GSM526292","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human adjacent normal prostate","Homo sapiens","sample id: PAN0109","tissue: Prostate","disease status: normal adjacent benign prostate","","","","","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526292/GSM526292_YX_Exon1_PAN0109.CEL.gz","804085","Alternative to: GSM528023 (exon-level analysis)"
"GSM526293","Prostate normal PAN0110 exon","GSM526293","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human adjacent normal prostate","Homo sapiens","sample id: PAN0110","tissue: Prostate","disease status: normal adjacent benign prostate","","","","","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526293/GSM526293_YX_Exon1_PAN0110.CEL.gz","804085","Alternative to: GSM528024 (exon-level analysis)"
"GSM526294","Prostate normal PAN0112 exon","GSM526294","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human adjacent normal prostate","Homo sapiens","sample id: PAN0112","tissue: Prostate","disease status: normal adjacent benign prostate","","","","","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526294/GSM526294_YX_Exon1_PAN0112.CEL.gz","804085","Alternative to: GSM528025 (exon-level analysis)"
"GSM526295","Prostate normal PAN0113 exon","GSM526295","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human adjacent normal prostate","Homo sapiens","sample id: PAN0113","tissue: Prostate","disease status: normal adjacent benign prostate","","","","","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526295/GSM526295_YX_Exon1_PAN0113.CEL.gz","804085","Alternative to: GSM528026 (exon-level analysis)"
"GSM526296","Prostate normal PAN0114 exon","GSM526296","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human adjacent normal prostate","Homo sapiens","sample id: PAN0114","tissue: Prostate","disease status: normal adjacent benign prostate","","","","","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526296/GSM526296_YX_Exon1_PAN0114.CEL.gz","804085","Alternative to: GSM528027 (exon-level analysis)"
"GSM526297","Prostate normal PAN0115 exon","GSM526297","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human adjacent normal prostate","Homo sapiens","sample id: PAN0115","tissue: Prostate","disease status: normal adjacent benign prostate","","","","","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526297/GSM526297_YX_Exon1_PAN0115.CEL.gz","804085","Alternative to: GSM528028 (exon-level analysis)"
"GSM526298","Prostate normal PAN0117 exon","GSM526298","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human adjacent normal prostate","Homo sapiens","sample id: PAN0117","tissue: Prostate","disease status: normal adjacent benign prostate","","","","","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526298/GSM526298_YX_Exon1_PAN0117.CEL.gz","804085","Alternative to: GSM528029 (exon-level analysis)"
"GSM526299","Prostate normal PAN0120 exon","GSM526299","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human adjacent normal prostate","Homo sapiens","sample id: PAN0120","tissue: Prostate","disease status: normal adjacent benign prostate","","","","","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526299/GSM526299_YX_Exon1_PAN0120.CEL.gz","804085","Alternative to: GSM528030 (exon-level analysis)"
"GSM526300","Prostate normal PAN0122 exon","GSM526300","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human adjacent normal prostate","Homo sapiens","sample id: PAN0122","tissue: Prostate","disease status: normal adjacent benign prostate","","","","","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526300/GSM526300_YX_Exon1_PAN0122.CEL.gz","804085","Alternative to: GSM528031 (exon-level analysis)"
"GSM526301","Prostate normal PAN0125 exon","GSM526301","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human adjacent normal prostate","Homo sapiens","sample id: PAN0125","tissue: Prostate","disease status: normal adjacent benign prostate","","","","","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526301/GSM526301_YX_Exon1_PAN0125.CEL.gz","804085","Alternative to: GSM528032 (exon-level analysis)"
"GSM526302","Prostate normal PAN0127 exon","GSM526302","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human adjacent normal prostate","Homo sapiens","sample id: PAN0127","tissue: Prostate","disease status: normal adjacent benign prostate","","","","","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526302/GSM526302_YX_Exon1_PAN0127.CEL.gz","804085","Alternative to: GSM528033 (exon-level analysis)"
"GSM526303","Prostate normal PAN0128 exon","GSM526303","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human adjacent normal prostate","Homo sapiens","sample id: PAN0128","tissue: Prostate","disease status: normal adjacent benign prostate","","","","","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526303/GSM526303_YX_Exon1_PAN0128.CEL.gz","804085","Alternative to: GSM528034 (exon-level analysis)"
"GSM526304","Prostate normal PAN0129 exon","GSM526304","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human adjacent normal prostate","Homo sapiens","sample id: PAN0129","tissue: Prostate","disease status: normal adjacent benign prostate","","","","","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526304/GSM526304_YX_Exon1_PAN0129.CEL.gz","804085","Alternative to: GSM528035 (exon-level analysis)"
"GSM526305","Prostate normal PAN0134 exon","GSM526305","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human adjacent normal prostate","Homo sapiens","sample id: PAN0134","tissue: Prostate","disease status: normal adjacent benign prostate","","","","","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526305/GSM526305_YX_Exon1_PAN0134.CEL.gz","804085","Alternative to: GSM528036 (exon-level analysis)"
"GSM526306","Prostate normal PAN0135 exon","GSM526306","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human adjacent normal prostate","Homo sapiens","sample id: PAN0135","tissue: Prostate","disease status: normal adjacent benign prostate","","","","","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526306/GSM526306_YX_Exon1_PAN0135.CEL.gz","804085","Alternative to: GSM528037 (exon-level analysis)"
"GSM526307","Prostate normal PAN0136 exon","GSM526307","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human adjacent normal prostate","Homo sapiens","sample id: PAN0136","tissue: Prostate","disease status: normal adjacent benign prostate","","","","","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526307/GSM526307_YX_Exon1_PAN0136.CEL.gz","804085","Alternative to: GSM528038 (exon-level analysis)"
"GSM526308","Prostate normal PAN0144 exon","GSM526308","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human adjacent normal prostate","Homo sapiens","sample id: PAN0144","tissue: Prostate","disease status: normal adjacent benign prostate","","","","","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526308/GSM526308_YX_Exon1_PAN0144.CEL.gz","804085","Alternative to: GSM528039 (exon-level analysis)"
"GSM526309","Prostate normal PAN0147 exon","GSM526309","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human adjacent normal prostate","Homo sapiens","sample id: PAN0147","tissue: Prostate","disease status: normal adjacent benign prostate","","","","","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526309/GSM526309_YX_Exon1_PAN0147.CEL.gz","804085","Alternative to: GSM528040 (exon-level analysis)"
"GSM526310","Prostate normal PAN0151 exon","GSM526310","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human adjacent normal prostate","Homo sapiens","sample id: PAN0151","tissue: Prostate","disease status: normal adjacent benign prostate","","","","","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526310/GSM526310_YX_Exon1_PAN0151.CEL.gz","804085","Alternative to: GSM528041 (exon-level analysis)"
"GSM526311","Prostate normal PAN0157 exon","GSM526311","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human adjacent normal prostate","Homo sapiens","sample id: PAN0157","tissue: Prostate","disease status: normal adjacent benign prostate","","","","","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526311/GSM526311_YX_Exon1_PAN0157.CEL.gz","804085","Alternative to: GSM528042 (exon-level analysis)"
"GSM526312","Prostate normal PAN0162 exon","GSM526312","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human adjacent normal prostate","Homo sapiens","sample id: PAN0162","tissue: Prostate","disease status: normal adjacent benign prostate","","","","","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526312/GSM526312_YX_Exon1_PAN0162.CEL.gz","804085","Alternative to: GSM528043 (exon-level analysis)"
"GSM526313","Prostate normal PAN0164 exon","GSM526313","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human adjacent normal prostate","Homo sapiens","sample id: PAN0164","tissue: Prostate","disease status: normal adjacent benign prostate","","","","","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526313/GSM526313_YX_Exon1_PAN0164.CEL.gz","804085","Alternative to: GSM528044 (exon-level analysis)"
"GSM526314","Prostate normal PAN0167 exon","GSM526314","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human adjacent normal prostate","Homo sapiens","sample id: PAN0167","tissue: Prostate","disease status: normal adjacent benign prostate","","","","","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526314/GSM526314_YX_Exon1_PAN0167.CEL.gz","804085","Alternative to: GSM528045 (exon-level analysis)"
"GSM526315","Prostate normal PAN0169 exon","GSM526315","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human adjacent normal prostate","Homo sapiens","sample id: PAN0169","tissue: Prostate","disease status: normal adjacent benign prostate","","","","","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526315/GSM526315_YX_Exon1_PAN0169.CEL.gz","804085","Alternative to: GSM528046 (exon-level analysis)"
"GSM526316","Prostate normal PAN0171 exon","GSM526316","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human adjacent normal prostate","Homo sapiens","sample id: PAN0171","tissue: Prostate","disease status: normal adjacent benign prostate","","","","","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526316/GSM526316_YX_Exon1_PAN0171.CEL.gz","804085","Alternative to: GSM528047 (exon-level analysis)"
"GSM526317","Prostate normal PAN0172 exon","GSM526317","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human adjacent normal prostate","Homo sapiens","sample id: PAN0172","tissue: Prostate","disease status: normal adjacent benign prostate","","","","","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526317/GSM526317_YX_Exon1_PAN0172.CEL.gz","804085","Alternative to: GSM528048 (exon-level analysis)"
"GSM526318","Prostate normal PAN0174 exon","GSM526318","Public on Jun 24 2010","Mar 24 2010","Jun 15 2010","RNA","1","human adjacent normal prostate","Homo sapiens","sample id: PAN0174","tissue: Prostate","disease status: normal adjacent benign prostate","","","","","total RNA","Total RNA was isolaged using TRIzol@Reagent Total RNA Isoloation (Invitrogen), quantified with Thermo Scientific NanoDrop 1000 Spectrophotometer, and quality controlled with RNA 6000 picoAssay and Bioanalyzer 2100 (Agilent).","biotin","Per manufacturer's instructions with the Affymetrix WT Sense Target Labeling Assay","9606","Per manufacturer's instructions","Affymetrix high-numeric aperture and flying objective lens (FOL) GS3000 scanner","exon and whole-transcript expression profiling","Images were quantified using the GeneChip Operating Software (GCOS) version 1.4. Data were processed with Aroma Affymetrix using standard RMA background adjustment and quantile normalization","GPL5188","Barry,Stephen,Taylor","Memorial Sloan-Kettering Cancer Center","1275 York Avenue, Box #460","New York","NY","10065","USA","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM526nnn/GSM526318/GSM526318_YX_Exon1_PAN0174.CEL.gz","804085","Alternative to: GSM528049 (exon-level analysis)"
